Table 5.
Treatment outcomes of medication on patients with cystic echinococcosis
| General condition | Total | Treatment outcome(n, %) | χ2trend | P | |||
|---|---|---|---|---|---|---|---|
| Cured | Effective | Ineffective | Relapsed | ||||
| Actual albendazole administration duration (months) | |||||||
| < 6 | 34 | 0 | 7 (20.6) | 27 (79.4) | 0 | 0.28 | < 0.05 |
| 6–12 | 30 | 0 | 7 (23.3) | 22 (73.3) | 1 (3.3) | ||
| 12–36 | 43 | 3 (7.0) | 15 (34.9) | 23 (53.5) | 2 (4.7) | ||
| ≥ 36 | 67 | 6 (9.0) | 27 (40.3) | 32 (47.8) | 2 (3.0) | ||
| Medication | |||||||
| No medication | 16 | 0 | 0 | 15 (93.8) | 1 (6.3) | 0.47 | < 0.05 |
| Irregular medication | 93 | 0 | 21 (22.6) | 68 (73.1) | 4 (4.3) | ||
| Regular medication | 65 | 9 (13.9) | 35 (53.9) | 21 (32.3) | 0 | ||